Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2025 07:45 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect to have investigational product of TNX-4800 (anti-Borrelia...
December 29, 2025 07:45 ET | Source: Fusion Fuel Green PLC

Fusion Fuel’s BrightHy Solutions Signs Agreements to Launch Up to €30 Million Targeted Hydrogen Investment Platform

Deployment of up to €30 million of Partner-committed capital, to be released over time in three potential tranches of €10 million each.First project expected to be a green hydrogen production facility...
December 29, 2025 07:30 ET | Source: Zevra Therapeutics

Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)

CELEBRATION, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living...
December 29, 2025 07:20 ET | Source: Polyrizon Ltd.

Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet

Company to Continue Advancing Product Development and Regulatory Progress of Its Core Medical Pipeline Raanana, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon Ltd. (Nasdaq:...
December 29, 2025 07:05 ET | Source: Unicycive Therapeutics, Inc.

Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)

LOS ALTOS, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for...
December 29, 2025 07:00 ET | Source: Society Pass Incorporated

Society Pass Incorporated (Nasdaq: SOPA) and Thoughtful Media Group Incorporated

Target US$90 Billion Southeast Asian Live Commerce Market andLaunch Live Selling Platform for Regional Brands and Creators NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Society Pass Incorporated....
December 29, 2025 07:00 ET | Source: Anfield Energy Inc.

Anfield Energy Announces Appointment of Lubica Niemann as Chief Financial Officer

VANCOUVER, British Columbia, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce that it has appointed...
December 29, 2025 07:00 ET | Source: Bluejay Diagnostics, Inc.

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal...
December 29, 2025 07:00 ET | Source: Baker Hughes

Baker Hughes Announces Dates for Fourth-quarter and Full-year 2025 Earnings Release and Webcast

HOUSTON and LONDON, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR) will announce the results of the fourth quarter and full year ending Dec. 31, 2025, via press release at 5 p.m....
December 29, 2025 07:00 ET | Source: REE Automotive Ltd.

REE Automotive Expected to Supply Cascadia Motion with Corner Technology Used in Electric Drive Units for Global OEM Market

Cascadia Motions (a wholly owned subsidiary of BorgWarner Inc.) to manufacture, commercialize, and sell a new generation of compact electric drive unit (EDU) integrating REEcorner technology with...